Zelalem Eshete

Array ( [id] => 9331299 [patent_doc_number] => 20140058081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'METHOD FOR PREPARING 42-(DIMETHYLPHOSPHINATE) RAPAMYCIN' [patent_app_type] => utility [patent_app_number] => 13/967597 [patent_app_country] => US [patent_app_date] => 2013-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5342 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13967597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11684961 [patent_doc_number] => 09682997 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-20 [patent_title] => 'Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin SV and 3-formylrifamycin S and a process of their preparation' [patent_app_type] => utility [patent_app_number] => 14/421364 [patent_app_country] => US [patent_app_date] => 2013-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3251 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10325715 [patent_doc_number] => 20150210719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'ANTIBACTERIAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/417511 [patent_app_country] => US [patent_app_date] => 2013-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26386 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10574133 [patent_doc_number] => 09296760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-29 [patent_title] => 'Antibacterial compounds' [patent_app_type] => utility [patent_app_number] => 14/419463 [patent_app_country] => US [patent_app_date] => 2013-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27764 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9306533 [patent_doc_number] => 20140045207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES' [patent_app_type] => utility [patent_app_number] => 13/962636 [patent_app_country] => US [patent_app_date] => 2013-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31864 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13962636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10476042 [patent_doc_number] => 20150361059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'SUBSTITUTED HETERO-AZEPINONES' [patent_app_type] => utility [patent_app_number] => 14/418383 [patent_app_country] => US [patent_app_date] => 2013-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61462 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14418383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10318490 [patent_doc_number] => 20150203492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'DIHYDROPYRIDONE P1 AS FACTOR XIA INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/419002 [patent_app_country] => US [patent_app_date] => 2013-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 114740 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9643293 [patent_doc_number] => 20140221405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'PLATELET ADP RECEPTOR INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/956251 [patent_app_country] => US [patent_app_date] => 2013-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22502 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13956251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676980 [patent_doc_number] => 08815888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Forms of rifaximin and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/955660 [patent_app_country] => US [patent_app_date] => 2013-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 80 [patent_no_of_words] => 26692 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13955660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503589 [patent_doc_number] => 08741904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations' [patent_app_type] => utility [patent_app_number] => 13/950642 [patent_app_country] => US [patent_app_date] => 2013-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4378 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13950642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9162131 [patent_doc_number] => 20130310409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'FORMS OF RIFAXIMIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/949684 [patent_app_country] => US [patent_app_date] => 2013-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 28901 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13949684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9162091 [patent_doc_number] => 20130310368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/947995 [patent_app_country] => US [patent_app_date] => 2013-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 84716 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13947995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10298790 [patent_doc_number] => 20150183789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'IMPROVED PROCESS FOR THE PREPARATION OF PRALATREXATE' [patent_app_type] => utility [patent_app_number] => 14/416127 [patent_app_country] => US [patent_app_date] => 2013-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8798 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9440936 [patent_doc_number] => 08710047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => '5-HT3 receptor modulators, methods of making, and use thereof' [patent_app_type] => utility [patent_app_number] => 13/941304 [patent_app_country] => US [patent_app_date] => 2013-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36138 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9692083 [patent_doc_number] => 08822678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Method for synthesizing temsirolimus' [patent_app_type] => utility [patent_app_number] => 13/933118 [patent_app_country] => US [patent_app_date] => 2013-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3199 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13933118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10451901 [patent_doc_number] => 20150336915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'STRUCTURES OF PROTEASOME INHIBITORS AND METHODS FOR SYNTHESIZING AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/410474 [patent_app_country] => US [patent_app_date] => 2013-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 13889 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9490675 [patent_doc_number] => 20140141081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'FORMS OF RIFAXIMIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/929003 [patent_app_country] => US [patent_app_date] => 2013-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 21975 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9589393 [patent_doc_number] => 08778933 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Diazepinedione derivative' [patent_app_type] => utility [patent_app_number] => 13/921382 [patent_app_country] => US [patent_app_date] => 2013-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9907 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11790055 [patent_doc_number] => 09399627 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-26 [patent_title] => 'Substituted macrocyclic compounds having proteasome inhibitory activity' [patent_app_type] => utility [patent_app_number] => 14/408140 [patent_app_country] => US [patent_app_date] => 2013-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17343 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10399398 [patent_doc_number] => 20150284407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'POLYMORPHIC FORMS OF RIFAXIMIN' [patent_app_type] => utility [patent_app_number] => 14/408251 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9818 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408251 [rel_patent_id] =>[rel_patent_doc_number] =>)